Genscript Biotech Corp (1548.HK)
Company Info
ISIN | KYG3825B1059 |
---|---|
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | HK$27.97B |
---|---|
Year Range | HK$7.43 - HK$24.95 |
Target Price | HK$25.84 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Genscript Biotech Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Genscript Biotech Corp had a return of -30.11% year-to-date (YTD) and -31.63% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -30.11% | 19.70% |
1 month | 19.66% | 1.08% |
6 months | -3.48% | 9.56% |
1 year | -31.63% | 34.99% |
5 years (annualized) | -1.24% | 14.15% |
10 years (annualized) | N/A | 11.26% |
Monthly Returns
The table below presents the monthly returns of 1548.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | -34.74% | 22.07% | -8.34% | -19.72% | -14.09% | -16.80% | 49.52% | -4.98% | 17.94% | -30.11% | |||
2023 | 6.44% | -18.90% | -21.68% | 22.62% | -15.92% | 1.62% | 13.41% | -7.92% | 12.35% | 9.93% | -4.41% | -8.48% | -20.08% |
2022 | -28.55% | 25.15% | -18.64% | -9.36% | 1.98% | 22.63% | -0.18% | -10.39% | -32.57% | 15.62% | -0.40% | 25.76% | -27.97% |
2021 | -12.23% | 35.15% | 2.24% | 31.58% | 69.17% | 11.33% | 0.59% | 8.36% | -18.81% | 15.17% | 18.67% | -15.85% | 205.85% |
2020 | 1.92% | -10.09% | -22.56% | 10.19% | 22.83% | -5.67% | 5.40% | -10.83% | -15.35% | -15.30% | 3.72% | 1.26% | -35.89% |
2019 | 14.01% | 21.93% | 0.95% | 34.95% | -15.30% | 15.82% | -1.12% | -9.38% | -14.56% | 25.43% | 0.32% | -6.35% | 67.61% |
2018 | 42.39% | -17.40% | 6.81% | 6.18% | 9.94% | -25.94% | -11.52% | -11.98% | -21.78% | -9.53% | 13.71% | -22.35% | -47.15% |
2017 | -5.41% | 16.00% | 3.45% | -17.62% | -4.62% | 28.33% | -1.42% | 73.80% | 3.18% | 27.75% | 4.20% | 101.21% | 441.89% |
2016 | 4.54% | -2.90% | 2.24% | -8.75% | -3.21% | -1.65% | 5.05% | 74.40% | 0.46% | 45.20% | 26.10% | -7.73% | 180.31% |
2015 | 0.00% | 0.00% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1548.HK is 24, indicating that it is in the bottom 24% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Genscript Biotech Corp (1548.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Genscript Biotech Corp granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|---|
Dividend | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
Dividend yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% |
Monthly Dividends
The table displays the monthly dividend distributions for Genscript Biotech Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | ||
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
2017 | HK$0.01 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.01 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Genscript Biotech Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Genscript Biotech Corp was 80.38%, occurring on Jun 3, 2024. The portfolio has not yet recovered.
The current Genscript Biotech Corp drawdown is 66.91%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-80.38% | Jul 20, 2021 | 707 | Jun 3, 2024 | — | — | — |
-70.7% | Jan 30, 2018 | 224 | Dec 27, 2018 | 597 | Jun 3, 2021 | 821 |
-41.28% | Mar 21, 2017 | 44 | May 26, 2017 | 66 | Aug 30, 2017 | 110 |
-37.35% | Jan 20, 2016 | 86 | May 27, 2016 | 62 | Aug 26, 2016 | 148 |
-25.98% | Sep 15, 2017 | 10 | Sep 28, 2017 | 8 | Oct 12, 2017 | 18 |
Volatility
Volatility Chart
The current Genscript Biotech Corp volatility is 25.08%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Genscript Biotech Corp.
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |